Announcements Trials

Browse Landscape

Status

Active not recruiting 2 Unknown 1 Terminated 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Lung Neoplasms 3 Small Cell Lung Carcinoma 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Vascular Neoplasms 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Tongue Neoplasms 1 Tobacco Use Disorder 1 Stomach Neoplasms 1 Solid Tumor, Adult 1 Prostatic Neoplasms 1 Neoplasms 1 Mouth Neoplasms 1 MR-PET Imaging 1 Hip Fractures 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Bone Cysts, Aneurysmal 1 Bone Cysts 1

Interventions

Exercise 18 Drug Therapy 17 pembrolizumab 12 Capecitabine 11 Blood Specimen Collection 11 Surveys and Questionnaires 10 Radiotherapy 10 Dexamethasone 9 Paclitaxel 8 Standard of Care 7 Oxaliplatin 7 Nivolumab 7 Fluorouracil 7 Erlotinib Hydrochloride 7 apatinib 6 Interviews as Topic 6 Gemcitabine 6 Cisplatin 6 Therapeutics 5 Neoadjuvant Therapy 5 Mindfulness-Based Cognitive Therapy 5 Metformin 5 Injections 5 Everolimus 5 Docetaxel 5 Cyclophosphamide 5 Control Groups 5 Bevacizumab 5 sintilimab 4 atezolizumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasms × X-Rays × Clear all

NCT06067035 2023-10-04

IMAHEP

Assistance Publique - Hôpitaux de Paris

Neoplasms, Vascular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡